Executives from seven major drugmakers, including Bristol-Myers Squibb Co., Merck & Co. and Pfizer are set to testify before the Senate Finance Committee on drug prices.
Executives from seven major drugmakers, including Bristol-Myers Squibb Co., Merck & Co. and Pfizer are set to testify before the Senate Finance Committee on drug prices.